Through 2022, the infectious disease treatment market is expected to experience substantial growth, according to a Brisk Insights report.
Here are four things to know:
1. The market is projected to increase at a compound annual growth rate of 8.2 percent from 2015 to 2022.
2. The increasing prevalence of infectious disease and better infectious disease management and control are fueling market growth.
3. Additionally, more research and development initiatives and increasing demand for personalized medicines are driving market growth.
4. Asia Pacific is expected to experience swift growth due to high incidence of infectious diseases in this region.
More articles on quality & infection control:
Medicaid & commercial payers forgo restrictions on costly hepatitis C medications: 7 notes
Senate Democrats urge Zika funding finalization: 4 things to know
The never-event costing the US healthcare system billions & how Stryker is taking the lead to change that
